Find out more about what Universal Credit is, when and how it's being introduced, the benefits it will be replacing, how the new system might affect you and how the Cystic Fibrosis Trust can help. *This news story was updated on 04/10/18*
During the UK CF Conference this month we launched the Clinical Trials Accelerator Platform with a call for a Patient and Public Involvement advisor - but what is it, and why should you apply?
Last week over 2,500 biomedical scientists, doctors and healthcare professionals from 58 countries visited Liverpool to attend the European Cystic Fibrosis Society (ECFS) Conference. Research conferences are an important way to advance our knowledge of CF and how to treat it, identify where the gaps in our knowledge are – and how to plug them – and most importantly, to keep research relevant to the CF community. Below are three of our highlights from the conference.
Today is Ada Lovelace Day, a day to celebrate the achievements of women in science and engineering. To mark the occasion, we caught up with Dr Paola Vergani, senior lecturer and Trust-funded researcher based at University College London. We learned about her recent research on the cystic fibrosis (CF) protein and how she’s passing on an enthusiasm in CF research to the next generation of doctors and researchers.
In a Science Media Centre briefing today, we explained to journalists why we are continuing to fund world-leading and cutting edge research to get better cystic fibrosis (CF) drugs to market, to have treatments for everyone with CF, including those not eligible or tolerant of existing drugs, and to massively reduce the impact of CF-related complications on their lives. Here, our Director of Research Dr Lucy Allen explains our plans.
As the Trust gets set to launch the second CF Insight Survey, we sat down with Head of Principal Involvement Paul Rymer, to see how your experiences are shaping our work, and how your stories are helping us turn up the volume on cystic fibrosis. Plus, we look at what’s new in this year’s survey.
